Press Release: DeoBioScience : Oncology Biotech Startup, DeoBioSciences, Retains Benzinga for 2022 Phase of Investor Marketing Campaign

/PRNewswire/ -- In 2022, DeoBioSciences is continuing its first equity crowdfunding offering to retail and institutional investors at Netcapital.com to finance...